In our group of T1D adolescents with average diabetes duration of seven years, TGF-β1 mRNA levels could be used as a potential biomarker for CVD risk assessment indicating not only dysregulation of immune response to autoantigens, but also predicting future cardiovascular complications. The gene discussed is TGFB1; the disease is type 1 diabetes mellitus.